Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene

Archives of Biochemistry and Biophysics

Volumn 350, Issue 2, 1998, Pages 340-347

  Schuetz, Erin G ^a   Yasuda, Kazuto ^b   Arimori, Kazuhiko ^b   Schuetz, John D ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Benzo(a)pyrene; Cytochrome P4503A; Erythromycin; P glycoprotein; Retinoic acid

Indexed keywords

BENZO[A]PYRENE; ERYTHROMYCIN; GLYCOPROTEIN P; RETINOIC ACID;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELLULAR DISTRIBUTION; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG TRANSPORT; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0031850954     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1997.0537     Document Type: Article

References (34)

1. Schinkel A. H., Smit J. J., van Tellingen O. Cell. 77:1994;491-502.
2. Schinkel A. H., Wagenaar E., van Deemter L., Mol C., Borst P. J. Clin. Invest. 96:1995;1698-1705.
3. Ueda K., Okamura N., Hirai M. J. Biol. Chem. 267:1992;24248-24252.
4. Schinkel A. H., Wagensar E., Mol C. A., van Deemter L. J. Clin. Invest. 97:1996;2517-2524.
5. Sparreboom A., van Asperen J., Mayer U. Proc. Natl. Acad. Sci. USA. 94:1997;2031-2035.
6. Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I., Willingham M. C. Proc. Natl. Acad. Sci. USA. 84:1987;7735-7738.
7. Schuetz E. G., Schinkel A. H., Relling M. V., Schuetz J. D. Proc. Natl. Acad. Sci. USA. 93:1996;4001-4005.
8. Lown K. S., Mayo R. R., Leichtman A. Clin. Pharmacol. Ther. 62:1997;248-260.
9. Schuetz E. G., Furuya K. N., Schuetz J. D. J. Pharmacol. Exp. Ther. 275:1995;1011-1018.
10. Schuetz E. G., Schuetz J. D., Thompson M. T., Fisher R. A., Madariage J. R., Strom S. C. Mol. Carcinogen. 12:1995;61-65.
11. Bain L. J., Leblanc G. A. Toxicol. Appl. Pharmacol. 141:1996;288-298.
12. Nogae I., Kikuchi J., Yamaguchi T., Nakagawa M., Shiraishi N., Kuwano M. Br. J. Cancer. 30:1987;267-272.
13. Hofsli E., Nissen-Meyer J. Int. J. Cancer. 44:1989;149-154.
14. Schuetz E. G., Beck W. T., Schuetz J. D. Mol. Pharmacol. 49:1996;311-318.
15. Saeki T., Ueda K., Tanigawara Y., Hori R., Komano T. J. Biol. Chem. 268:1993;6077-6080.
16. Yeh G. C., Lopaczynska J., Poore C. M., Phang J. P. Cancer Res. 20:1992;6692-6695.
17. Scala S., Akhmed N., Rao U. S. Mol. Pharmacol. 51:1997;1024-1033.
18. Schinkel A. H., Mayer U., Wagenaar E. Proc. Natl. Acad. Sci. USA. 94:1997;4028-4033.
19. Kizaki M., Ueno H., Yamazoe Y. Blood. 87:1996;725-733.
20. Watkins P. B., Murray S. A., Winkelman L. G., Heuman D. M., Wrighton S. A., Guzelian P. S. J. Clin. Invest. 83:1989;688-697.
21. Borst P., Schinkel A. H. Eur. J. Cancer. 32A:1996;985-990.
22. Penny J. I., Campbell F. C. Biochim. Biophys. Acta. 1226:1994;232-236.
23. Muindi J., Frankel S. R., Miller W. H. Blood. 79:1992;299-313.
24. Warrell R. P. Blood. 82:1993;1949-1953.
25. Chun A., Seitz J. A. Infection Suppl. 1:1977;14-22.
26. Gupta S. K., Bakran A., Johnson R. W. G., Rowland M. Br. J. Clin. Pharmacol. 27:1989;475-481.
27. Watkins P. B. Pharmacogenetics. 4:1994;171-184.
28. Watkins P. B., Wrighton S. A., Maurel P. Proc. Natl. Acad. Sci. USA. 82:1985;6310-6314.
29. Watkins P. B., Hamilton T. A., Annesley T. M., Ellis C. N., Kolars J. C., Voorhees J. J. Clin. Pharmacol. Ther. 48:1990;120-129.
30. Shimada T., Yamazake H., Mimura M., Inui Y., Guengerich F. P. J. Pharmacol. Exp. Ther. 270:1994;414-423.
31. Kinirons M. T., O'Shea D., Downing T. E. Clin. Pharmacol. Ther. 54:1993;621-629.
32. Relling M. V., Nemec J., Schuetz E. G., Schuetz J. D., Gonzalez F. J., Korzekwa K. R. Mol. Pharmacol. 45:1994;352-358.
33. Sonnichsen D. S., Liu Q., Schuetz E. G., Schuetz J. D., Pappo A., Relling M. V. J. Pharmacol. Exp. Ther. 275:1995;566-575.
34. Roepe P. D., Wei L., Hoffman M. M., Fritz F. J. Bioenerg. Biomembr. 28:1996;541-555.